BRD10
gene geneOn this page
Also known as FLJ20375
Summary
BRD10 (bromodomain containing 10, HGNC:23378) is a protein-coding gene on chromosome 9p24.1, encoding Uncharacterized bromodomain-containing protein 10 (Q5HYC2).
Predicted to be located in nucleus.
Source: NCBI Gene 158358 — RefSeq curated summary.
At a glance
- GWAS associations: 9
- Clinical variants (ClinVar): 454 total
- MANE Select transcript:
NM_001017969
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23378 |
| Approved symbol | BRD10 |
| Name | bromodomain containing 10 |
| Location | 9p24.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ20375 |
| Ensembl gene | ENSG00000183354 |
| Ensembl biotype | protein_coding |
| Entrez | 158358 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 3 protein_coding, 2 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000381461, ENST00000399933, ENST00000436015, ENST00000443149, ENST00000513355, ENST00000540714
RefSeq mRNA: 1 — MANE Select: NM_001017969
NM_001017969
Canonical transcript exons
ENST00000399933 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001488661 | 5919022 | 5923309 |
| ENSE00001540841 | 5968019 | 5969436 |
| ENSE00001540843 | 5988345 | 5988545 |
| ENSE00001635174 | 5954016 | 5954095 |
| ENSE00001791565 | 5944871 | 5944960 |
| ENSE00003484761 | 5929044 | 5929159 |
| ENSE00003626549 | 5924658 | 5924845 |
| ENSE00003849730 | 6007195 | 6008482 |
Expression profiles
Bgee: expression breadth ubiquitous, 253 present calls, max score 96.53.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 5.2202 / max 74.3740, expressed in 1615 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 99848 | 3.3171 | 1373 |
| 99845 | 0.8384 | 435 |
| 99847 | 0.6556 | 349 |
| 99846 | 0.4033 | 192 |
| 99843 | 0.0058 | 1 |
Top tissues by expression
255 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| epithelial cell of pancreas | CL:0000083 | 96.53 | gold quality |
| pancreatic ductal cell | CL:0002079 | 95.05 | gold quality |
| cerebellar vermis | UBERON:0004720 | 93.63 | gold quality |
| sural nerve | UBERON:0015488 | 92.99 | gold quality |
| medial globus pallidus | UBERON:0002477 | 92.90 | gold quality |
| calcaneal tendon | UBERON:0003701 | 92.86 | gold quality |
| kidney epithelium | UBERON:0004819 | 92.20 | gold quality |
| globus pallidus | UBERON:0001875 | 91.60 | gold quality |
| tendon | UBERON:0000043 | 91.54 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 91.50 | gold quality |
| corpus callosum | UBERON:0002336 | 91.35 | gold quality |
| cortical plate | UBERON:0005343 | 90.75 | gold quality |
| tibialis anterior | UBERON:0001385 | 90.30 | gold quality |
| deltoid | UBERON:0001476 | 90.25 | gold quality |
| medulla oblongata | UBERON:0001896 | 89.88 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 89.87 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 89.63 | gold quality |
| tibia | UBERON:0000979 | 89.62 | gold quality |
| oviduct epithelium | UBERON:0004804 | 89.51 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 89.33 | gold quality |
| cauda epididymis | UBERON:0004360 | 89.31 | gold quality |
| adrenal tissue | UBERON:0018303 | 89.26 | gold quality |
| mammary duct | UBERON:0001765 | 89.14 | gold quality |
| epithelium of mammary gland | UBERON:0003244 | 89.04 | gold quality |
| saphenous vein | UBERON:0007318 | 89.03 | gold quality |
| superior vestibular nucleus | UBERON:0007227 | 88.98 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 88.61 | gold quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 88.60 | gold quality |
| visceral pleura | UBERON:0002401 | 88.47 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 88.33 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.25 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
90 targeting BRD10, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-5692B | 100.00 | 71.32 | 2622 |
| HSA-MIR-5692C | 100.00 | 71.32 | 2622 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-33A-5P | 99.99 | 68.62 | 1055 |
| HSA-MIR-33B-5P | 99.99 | 68.58 | 1062 |
| HSA-MIR-4803 | 99.98 | 71.99 | 3117 |
| HSA-MIR-19A-3P | 99.98 | 75.33 | 2762 |
| HSA-MIR-19B-3P | 99.98 | 75.44 | 2754 |
| HSA-MIR-7152-3P | 99.97 | 67.47 | 849 |
| HSA-MIR-493-5P | 99.96 | 72.47 | 2382 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-LET-7C-3P | 99.95 | 73.42 | 2862 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
| HSA-MIR-144-3P | 99.94 | 73.98 | 2698 |
| HSA-MIR-548AE-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-548AH-3P | 99.93 | 72.54 | 4872 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Brd10 | ENSMUSG00000046138 |
| rattus_norvegicus | Brd10 | ENSRNOG00000026942 |
Protein
Protein identifiers
Uncharacterized bromodomain-containing protein 10 — Q5HYC2 (reviewed: Q5HYC2)
All UniProt accessions (4): F5H4E5, H0YFF4, H0YGV4, Q5HYC2
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Nucleus.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5HYC2-1 | 1 | yes |
| Q5HYC2-2 | 2 |
RefSeq proteins (1): NP_001017969* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001487 | Bromodomain | Domain |
| IPR036427 | Bromodomain-like_sf | Homologous_superfamily |
| IPR040214 | BRD10 | Family |
| IPR056522 | KIAA2026_hel | Domain |
Pfam: PF00439, PF23450
UniProt features (16 total): compositionally biased region 7, region of interest 6, chain 1, domain 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5HYC2-F1 | 46.10 | 0.12 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 79 (showing top):
TATTATA_MIR374, ATGCAGT_MIR217, GGGCATT_MIR365, TGTTTAC_MIR30A5P_MIR30C_MIR30D_MIR30B_MIR30E5P, ATGTACA_MIR493, TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C, GAGCCAG_MIR149, ARID5B_TARGET_GENES, NKX2_2_TARGET_GENES, ZBTB12_TARGET_GENES, ZNF407_TARGET_GENES, MIR8485, MIR548AJ_3P_MIR548X_3P, MIR1277_5P, MIR548AE_3P_MIR548AQ_3P
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
470 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| BRD10 | RIC1 | Q4ADV7 | 679 |
| BRD10 | ERMP1 | Q7Z2K6 | 602 |
| BRD10 | SLC66A3 | Q8N755 | 516 |
| BRD10 | SLC16A13 | Q7RTY0 | 509 |
| BRD10 | ETAA1 | Q9NY74 | 477 |
| BRD10 | PLGRKT | Q9HBL7 | 447 |
| BRD10 | UBTD1 | Q9HAC8 | 447 |
| BRD10 | RANBP6 | O60518 | 446 |
| BRD10 | NUDT11 | Q96G61 | 439 |
| BRD10 | CFAP73 | A6NFT4 | 418 |
| BRD10 | SPATA6L | Q8N4H0 | 412 |
| BRD10 | MKLN1 | Q9UL63 | 409 |
| BRD10 | MLANA | Q16655 | 387 |
| BRD10 | C1orf174 | Q8IYL3 | 374 |
| BRD10 | OSER1 | Q9NX31 | 370 |
| BRD10 | DMAC1 | Q96GE9 | 370 |
IntAct
8 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| BRD10 | KRT18 | psi-mi:“MI:0915”(physical association) | 0.400 |
| MYC | psi-mi:“MI:0914”(association) | 0.350 | |
| ATG16L1 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| BRD10 | psi-mi:“MI:0915”(physical association) | 0.000 | |
| ezrA | BRD10 | psi-mi:“MI:0915”(physical association) | 0.000 |
| BRD10 | CREB1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ATXN1 | BRD10 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (21): KIAA2026 (Synthetic Growth Defect), KIAA2026 (Affinity Capture-MS), KIAA2026 (Proximity Label-MS), KIAA2026 (Affinity Capture-RNA), KIAA2026 (Proximity Label-MS), KIAA2026 (Cross-Linking-MS (XL-MS)), KIAA2026 (Protein-RNA), KIAA2026 (Cross-Linking-MS (XL-MS)), KIAA2026 (Cross-Linking-MS (XL-MS)), KIAA2026 (Affinity Capture-MS), KIAA2026 (Affinity Capture-RNA), KIAA2026 (Proximity Label-MS), KIAA2026 (Proximity Label-MS), KIAA2026 (Proximity Label-MS), KIAA2026 (Proximity Label-MS)
ESM2 similar proteins: A0A1L8GR68, A2CG63, E9Q9M8, F7AQ22, G3V8T1, O75152, O75376, P49140, P51826, P97432, Q13625, Q14596, Q17R98, Q1LY51, Q3TYA6, Q4KKX4, Q4LE39, Q4R6F6, Q501R9, Q505G8, Q5F3Z9, Q5HYC2, Q5RC94, Q5XJV7, Q60974, Q68FE8, Q69Z61, Q6A098, Q6NXK2, Q6NZF1, Q6PJT7, Q6ZNC4, Q86YI8, Q8BFU3, Q8BJ05, Q8CCH7, Q8CG79, Q8CHY6, Q8K2W6, Q8ND24
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
454 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 422 |
| Likely benign | 17 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2672 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:5892550:GA:G | donor_gain | 1.0000 |
| 9:5892552:G:GG | donor_gain | 1.0000 |
| 9:5906878:A:AG | acceptor_gain | 1.0000 |
| 9:5906883:A:AG | acceptor_gain | 1.0000 |
| 9:5906883:AG:A | acceptor_gain | 1.0000 |
| 9:5906884:G:GA | acceptor_gain | 1.0000 |
| 9:5906884:GG:G | acceptor_gain | 1.0000 |
| 9:5906996:GTG:G | donor_gain | 1.0000 |
| 9:5906999:G:GG | donor_gain | 1.0000 |
| 9:5907000:T:A | donor_loss | 1.0000 |
| 9:5924652:GCTTA:G | donor_loss | 1.0000 |
| 9:5924653:CTTA:C | donor_loss | 1.0000 |
| 9:5924654:TTA:T | donor_loss | 1.0000 |
| 9:5924655:TACC:T | donor_loss | 1.0000 |
| 9:5924656:A:AC | donor_gain | 1.0000 |
| 9:5924656:ACCTG:A | donor_loss | 1.0000 |
| 9:5924657:C:CA | donor_loss | 1.0000 |
| 9:5924657:C:CC | donor_gain | 1.0000 |
| 9:5924716:A:AC | donor_gain | 1.0000 |
| 9:5924717:C:CC | donor_gain | 1.0000 |
| 9:5924841:GGCTC:G | acceptor_gain | 1.0000 |
| 9:5924843:CTC:C | acceptor_gain | 1.0000 |
| 9:5924844:TC:T | acceptor_gain | 1.0000 |
| 9:5924845:CC:C | acceptor_gain | 1.0000 |
| 9:5924846:C:CC | acceptor_gain | 1.0000 |
| 9:5924847:T:G | acceptor_loss | 1.0000 |
| 9:5924851:A:AC | acceptor_gain | 1.0000 |
| 9:5924851:A:C | acceptor_gain | 1.0000 |
| 9:5924856:A:AC | acceptor_gain | 1.0000 |
| 9:5924856:A:C | acceptor_gain | 1.0000 |
AlphaMissense
13635 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:5929081:A:G | W821R | 1.000 |
| 9:5929081:A:T | W821R | 1.000 |
| 9:5929101:A:G | L814P | 1.000 |
| 9:5944935:A:G | L773P | 1.000 |
| 9:5968847:C:G | G462R | 1.000 |
| 9:5920300:A:T | V1899D | 0.999 |
| 9:5922151:A:T | V1282D | 0.999 |
| 9:5929068:A:G | L825S | 0.999 |
| 9:5929079:C:A | W821C | 0.999 |
| 9:5929079:C:G | W821C | 0.999 |
| 9:5929089:A:G | L818S | 0.999 |
| 9:5929104:C:G | R813P | 0.999 |
| 9:5944935:A:T | L773H | 0.999 |
| 9:5944952:G:C | C767W | 0.999 |
| 9:5944954:A:G | C767R | 0.999 |
| 9:5968781:A:C | Y484D | 0.999 |
| 9:5968783:A:T | I483N | 0.999 |
| 9:5968786:C:G | R482P | 0.999 |
| 9:5968803:G:C | F476L | 0.999 |
| 9:5968803:G:T | F476L | 0.999 |
| 9:5968804:A:G | F476S | 0.999 |
| 9:5968805:A:G | F476L | 0.999 |
| 9:5968810:G:T | P474Q | 0.999 |
| 9:5968812:A:C | F473L | 0.999 |
| 9:5968812:A:T | F473L | 0.999 |
| 9:5968813:A:G | F473S | 0.999 |
| 9:5968814:A:G | F473L | 0.999 |
| 9:5968823:A:C | Y470D | 0.999 |
| 9:5968840:T:A | D464V | 0.999 |
| 9:5968846:C:A | G462V | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000001896 (9:6009235 C>A,G,T), RS1000006235 (9:5888399 A>T), RS1000054310 (9:5899100 A>G), RS1000068489 (9:6002453 T>C,G), RS1000070152 (9:5899702 A>G), RS1000104161 (9:5973062 G>C,T), RS1000106327 (9:5960778 A>G), RS1000107178 (9:5968769 G>C,T), RS1000116506 (9:5893641 G>C), RS1000121993 (9:5908139 T>G), RS1000147098 (9:5964931 A>G), RS1000161351 (9:5996691 T>C), RS1000162093 (9:5892027 T>C,G), RS1000163552 (9:6002263 T>C), RS1000205838 (9:5987261 A>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
9 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006988_5 | Blond vs. brown/black hair color | 6.000000e-10 |
| GCST007563_32 | Allergic disease (asthma, hay fever or eczema) | 4.000000e-08 |
| GCST008916_119 | Asthma | 1.000000e-15 |
| GCST008916_20 | Asthma | 5.000000e-36 |
| GCST008916_26 | Asthma | 3.000000e-64 |
| GCST009798_28 | Asthma | 4.000000e-18 |
| GCST009798_74 | Asthma | 2.000000e-15 |
| GCST009798_8 | Asthma | 5.000000e-67 |
| GCST90000025_462 | Appendicular lean mass | 3.000000e-12 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0003924 | hair color |
| EFO:0004980 | appendicular lean mass |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
PharmGKB variants
1 variants.
| Variant | Genes | Level | Score | #Clin annots | Drugs |
|---|---|---|---|---|---|
| rs10758713 | BRD10 | 0.00 | 0 |
CTD chemical–gene interactions
23 total (human), top 23 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, decreases expression, decreases methylation | 4 |
| aristolochic acid I | decreases expression | 1 |
| FR900359 | increases phosphorylation | 1 |
| bisphenol F | decreases expression, affects cotreatment | 1 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| sodium arsenite | increases expression | 1 |
| potassium chromate(VI) | affects cotreatment, decreases expression | 1 |
| epigallocatechin gallate | affects cotreatment, decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| entinostat | decreases expression | 1 |
| jinfukang | decreases expression | 1 |
| Sunitinib | increases expression | 1 |
| Vorinostat | decreases expression | 1 |
| Air Pollutants | affects expression, increases abundance | 1 |
| Dexamethasone | affects cotreatment, decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Indomethacin | decreases expression, affects cotreatment | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Urethane | increases expression | 1 |
| 1-Methyl-3-isobutylxanthine | affects cotreatment, decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Lactic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.